Doximity, Inc. (NASDAQ:DOCS) Stock Position Lifted by Banco Santander S.A.

Banco Santander S.A. boosted its stake in Doximity, Inc. (NASDAQ:DOCS) by 6.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,794 shares of the company’s stock after buying an additional 939 shares during the period. Banco Santander S.A.’s holdings in Doximity were worth $843,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of DOCS. FMR LLC boosted its holdings in shares of Doximity by 30.5% in the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after acquiring an additional 1,598,602 shares in the last quarter. State Street Corp boosted its stake in Doximity by 2.5% during the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company’s stock valued at $160,947,000 after purchasing an additional 88,922 shares in the last quarter. Geode Capital Management LLC boosted its stake in Doximity by 19.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock valued at $124,503,000 after purchasing an additional 472,565 shares in the last quarter. Los Angeles Capital Management LLC boosted its stake in Doximity by 33.7% during the 4th quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company’s stock valued at $46,466,000 after purchasing an additional 219,448 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Doximity by 3.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 778,524 shares of the company’s stock valued at $41,565,000 after purchasing an additional 25,523 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Doximity Price Performance

Shares of DOCS stock opened at $64.09 on Monday. The stock has a fifty day moving average price of $62.80 and a 200 day moving average price of $51.82. The stock has a market cap of $11.96 billion, a P/E ratio of 64.09, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a one year low of $22.96 and a one year high of $85.21.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on DOCS shares. Mizuho raised their price objective on Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. KeyCorp decreased their target price on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. Raymond James reaffirmed an “outperform” rating and set a $83.00 price objective (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Piper Sandler raised Doximity from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Finally, The Goldman Sachs Group boosted their target price on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, Doximity currently has an average rating of “Moderate Buy” and an average price target of $64.22.

Insider Transactions at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares in the company, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 37.40% of the stock is owned by insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.